Mourad W A, Katz R L, Sembera D, Atkinson E N, el-Naggar A K
Department of Pathology Biomathematics, University of Texas, M.D. Anderson Cancer Center, Texas 77030.
Diagn Cytopathol. 1992;8(2):128-34. doi: 10.1002/dc.2840080208.
Studies have shown that argyrophilic nucleolar organizer region-associated proteins (AgNORs) may correlate with DNA ploidy and/or proliferative activity in neoplastic and non-neoplastic conditions. However, studies have estimated only the mean AgNOR counts. Here we used two AgNOR counts, one of which may correlate with DNA ploidy and the other with proliferative activity. The mean AgNOR count (mAgNOR) was defined as the mean number of AgNORs/nucleus in 100 cells and may represent DNA or RNA index. The percentage of nuclei exhibiting 5 or more AgNORs/nucleus (pAgNOR) may reflect proliferative activity. These two AgNOR counts were correlated with results from acridine orange flow cytometry in 50 fine-needle aspirate (FNA) smears of nodal and extranodal sites, including three cases of reactive lymphadenopathy and 47 cases of non-Hodgkin's lymphoma. The mean mAgNOR count in the diploid specimens was 2.03 (+/- 0.74 SD) and 2.62 (+/- 0.73 SD) in the aneuploid tumors (P less than 0.0001). Samples with a low RNA index had mean mAgNOR of 1.80 (+/- 0.41 SD), whereas those with high RNA had a mean mAgNOR of 2.93 (+/- 0.86 SD) (P less than 0.0001). Lesions with low proliferative index, determined by flow cytometry, had a mean pAgNOR of 4%, whereas those with intermediate and high proliferative indices had a mean pAgNOR of 16% (P less than 0.0001). A similar but less significant correlation existed between RI and pAgNOR (P less than 0.005). We conclude that the two AgNOR counting methods may reliably reflect cell kinetics and distinguish ploidy from proliferative activity, making them useful adjuncts to flow cytometry in limited cytology specimens and small biopsy samples.
研究表明,嗜银核仁组织区相关蛋白(AgNORs)可能与肿瘤性和非肿瘤性病变中的DNA倍体和/或增殖活性相关。然而,以往研究仅估算了AgNOR的平均计数。在此,我们采用了两种AgNOR计数方法,其中一种可能与DNA倍体相关,另一种与增殖活性相关。平均AgNOR计数(mAgNOR)定义为100个细胞中每个细胞核的AgNOR平均数量,可能代表DNA或RNA指数。细胞核中显示5个或更多AgNOR/核的百分比(pAgNOR)可能反映增殖活性。在50例来自淋巴结和结外部位的细针穿刺(FNA)涂片(包括3例反应性淋巴结病和47例非霍奇金淋巴瘤)中,这两种AgNOR计数与吖啶橙流式细胞术的结果相关。二倍体标本的平均mAgNOR计数为2.03(±0.74标准差),非整倍体肿瘤为2.62(±0.73标准差)(P<0.0001)。RNA指数低的样本mAgNOR平均值为1.80(±0.41标准差),而RNA指数高的样本mAgNOR平均值为2.93(±0.86标准差)(P<0.0001)。通过流式细胞术确定增殖指数低的病变,其平均pAgNOR为4%,而增殖指数中等和高的病变平均pAgNOR为16%(P<0.0001)。RI与pAgNOR之间存在类似但不太显著的相关性(P<0.005)。我们得出结论,这两种AgNOR计数方法可可靠地反映细胞动力学,并区分倍体与增殖活性,使其成为有限细胞学标本和小活检样本中流式细胞术的有用辅助手段。